0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Companion Animal Specialty Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-12J4352
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Companion Animal Specialty Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Companion Animal Specialty Drugs Market Research Report 2025

Code: QYRE-Auto-12J4352
Report
August 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Companion Animal Specialty Drugs Market Size

The global market for Companion Animal Specialty Drugs was valued at US$ 13710 million in the year 2024 and is projected to reach a revised size of US$ 18640 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Companion Animal Specialty Drugs Market

Companion Animal Specialty Drugs Market

Companion Animal Specialty Drug is a kind of veterinary drugs that pet owners used to treatment and care of animals.
The Americas has the presence of large veterinary markets such as the US and Canada. The companion animal specialty drugs market is witnessing continuous growth in the region due to the rising awareness and the availability of companion animal healthcare. Furthermore, the increase in disposable incomes of pet owners and economic development, will also contribute to the growth of the market in this region.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Companion Animal Specialty Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Specialty Drugs.
The Companion Animal Specialty Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Companion Animal Specialty Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Animal Specialty Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Companion Animal Specialty Drugs Market Report

Report Metric Details
Report Name Companion Animal Specialty Drugs Market
Accounted market size in year US$ 13710 million
Forecasted market size in 2031 US$ 18640 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Vaccines
  • Antibiotics
  • Parasiticides
  • Feed Additives
  • Other
Segment by Application
  • Veterinary Hospitals
  • Pet Care Clinics
  • Pharmacy Stores
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Elanco, Merial, Zoetis, Aratana therapeutics, Beaphar, Henry Schein, Mars, The J.M Smucker Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Companion Animal Specialty Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Companion Animal Specialty Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Companion Animal Specialty Drugs Market growing?

Ans: The Companion Animal Specialty Drugs Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Companion Animal Specialty Drugs Market size in 2031?

Ans: The Companion Animal Specialty Drugs Market size in 2031 will be US$ 18640 million.

Who are the main players in the Companion Animal Specialty Drugs Market report?

Ans: The main players in the Companion Animal Specialty Drugs Market are Bayer, Elanco, Merial, Zoetis, Aratana therapeutics, Beaphar, Henry Schein, Mars, The J.M Smucker Company

What are the Application segmentation covered in the Companion Animal Specialty Drugs Market report?

Ans: The Applications covered in the Companion Animal Specialty Drugs Market report are Veterinary Hospitals, Pet Care Clinics, Pharmacy Stores

What are the Type segmentation covered in the Companion Animal Specialty Drugs Market report?

Ans: The Types covered in the Companion Animal Specialty Drugs Market report are Vaccines, Antibiotics, Parasiticides, Feed Additives, Other

1 Companion Animal Specialty Drugs Market Overview
1.1 Product Definition
1.2 Companion Animal Specialty Drugs by Type
1.2.1 Global Companion Animal Specialty Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vaccines
1.2.3 Antibiotics
1.2.4 Parasiticides
1.2.5 Feed Additives
1.2.6 Other
1.3 Companion Animal Specialty Drugs by Application
1.3.1 Global Companion Animal Specialty Drugs Market Value by Application (2024 VS 2031)
1.3.2 Veterinary Hospitals
1.3.3 Pet Care Clinics
1.3.4 Pharmacy Stores
1.4 Global Companion Animal Specialty Drugs Market Size Estimates and Forecasts
1.4.1 Global Companion Animal Specialty Drugs Revenue 2020-2031
1.4.2 Global Companion Animal Specialty Drugs Sales 2020-2031
1.4.3 Global Companion Animal Specialty Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Companion Animal Specialty Drugs Market Competition by Manufacturers
2.1 Global Companion Animal Specialty Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Companion Animal Specialty Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Companion Animal Specialty Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Companion Animal Specialty Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Companion Animal Specialty Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Companion Animal Specialty Drugs, Product Type & Application
2.7 Global Key Manufacturers of Companion Animal Specialty Drugs, Date of Enter into This Industry
2.8 Global Companion Animal Specialty Drugs Market Competitive Situation and Trends
2.8.1 Global Companion Animal Specialty Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Companion Animal Specialty Drugs Players Market Share by Revenue
2.8.3 Global Companion Animal Specialty Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Companion Animal Specialty Drugs Market Scenario by Region
3.1 Global Companion Animal Specialty Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Companion Animal Specialty Drugs Sales by Region: 2020-2031
3.2.1 Global Companion Animal Specialty Drugs Sales by Region: 2020-2025
3.2.2 Global Companion Animal Specialty Drugs Sales by Region: 2026-2031
3.3 Global Companion Animal Specialty Drugs Revenue by Region: 2020-2031
3.3.1 Global Companion Animal Specialty Drugs Revenue by Region: 2020-2025
3.3.2 Global Companion Animal Specialty Drugs Revenue by Region: 2026-2031
3.4 North America Companion Animal Specialty Drugs Market Facts & Figures by Country
3.4.1 North America Companion Animal Specialty Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Companion Animal Specialty Drugs Sales by Country (2020-2031)
3.4.3 North America Companion Animal Specialty Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Companion Animal Specialty Drugs Market Facts & Figures by Country
3.5.1 Europe Companion Animal Specialty Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Companion Animal Specialty Drugs Sales by Country (2020-2031)
3.5.3 Europe Companion Animal Specialty Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Companion Animal Specialty Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Companion Animal Specialty Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Companion Animal Specialty Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Companion Animal Specialty Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Companion Animal Specialty Drugs Market Facts & Figures by Country
3.7.1 Latin America Companion Animal Specialty Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Companion Animal Specialty Drugs Sales by Country (2020-2031)
3.7.3 Latin America Companion Animal Specialty Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Companion Animal Specialty Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Companion Animal Specialty Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Companion Animal Specialty Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Companion Animal Specialty Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Companion Animal Specialty Drugs Sales by Type (2020-2031)
4.1.1 Global Companion Animal Specialty Drugs Sales by Type (2020-2025)
4.1.2 Global Companion Animal Specialty Drugs Sales by Type (2026-2031)
4.1.3 Global Companion Animal Specialty Drugs Sales Market Share by Type (2020-2031)
4.2 Global Companion Animal Specialty Drugs Revenue by Type (2020-2031)
4.2.1 Global Companion Animal Specialty Drugs Revenue by Type (2020-2025)
4.2.2 Global Companion Animal Specialty Drugs Revenue by Type (2026-2031)
4.2.3 Global Companion Animal Specialty Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Companion Animal Specialty Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Companion Animal Specialty Drugs Sales by Application (2020-2031)
5.1.1 Global Companion Animal Specialty Drugs Sales by Application (2020-2025)
5.1.2 Global Companion Animal Specialty Drugs Sales by Application (2026-2031)
5.1.3 Global Companion Animal Specialty Drugs Sales Market Share by Application (2020-2031)
5.2 Global Companion Animal Specialty Drugs Revenue by Application (2020-2031)
5.2.1 Global Companion Animal Specialty Drugs Revenue by Application (2020-2025)
5.2.2 Global Companion Animal Specialty Drugs Revenue by Application (2026-2031)
5.2.3 Global Companion Animal Specialty Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Companion Animal Specialty Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Companion Animal Specialty Drugs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Company Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Elanco Companion Animal Specialty Drugs Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Merial
6.3.1 Merial Company Information
6.3.2 Merial Description and Business Overview
6.3.3 Merial Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merial Companion Animal Specialty Drugs Product Portfolio
6.3.5 Merial Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Company Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zoetis Companion Animal Specialty Drugs Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Aratana therapeutics
6.5.1 Aratana therapeutics Company Information
6.5.2 Aratana therapeutics Description and Business Overview
6.5.3 Aratana therapeutics Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aratana therapeutics Companion Animal Specialty Drugs Product Portfolio
6.5.5 Aratana therapeutics Recent Developments/Updates
6.6 Beaphar
6.6.1 Beaphar Company Information
6.6.2 Beaphar Description and Business Overview
6.6.3 Beaphar Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Beaphar Companion Animal Specialty Drugs Product Portfolio
6.6.5 Beaphar Recent Developments/Updates
6.7 Henry Schein
6.7.1 Henry Schein Company Information
6.7.2 Henry Schein Description and Business Overview
6.7.3 Henry Schein Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Henry Schein Companion Animal Specialty Drugs Product Portfolio
6.7.5 Henry Schein Recent Developments/Updates
6.8 Mars
6.8.1 Mars Company Information
6.8.2 Mars Description and Business Overview
6.8.3 Mars Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mars Companion Animal Specialty Drugs Product Portfolio
6.8.5 Mars Recent Developments/Updates
6.9 The J.M Smucker Company
6.9.1 The J.M Smucker Company Company Information
6.9.2 The J.M Smucker Company Description and Business Overview
6.9.3 The J.M Smucker Company Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 The J.M Smucker Company Companion Animal Specialty Drugs Product Portfolio
6.9.5 The J.M Smucker Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Companion Animal Specialty Drugs Industry Chain Analysis
7.2 Companion Animal Specialty Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Companion Animal Specialty Drugs Production Mode & Process Analysis
7.4 Companion Animal Specialty Drugs Sales and Marketing
7.4.1 Companion Animal Specialty Drugs Sales Channels
7.4.2 Companion Animal Specialty Drugs Distributors
7.5 Companion Animal Specialty Drugs Customer Analysis
8 Companion Animal Specialty Drugs Market Dynamics
8.1 Companion Animal Specialty Drugs Industry Trends
8.2 Companion Animal Specialty Drugs Market Drivers
8.3 Companion Animal Specialty Drugs Market Challenges
8.4 Companion Animal Specialty Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Companion Animal Specialty Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Companion Animal Specialty Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Companion Animal Specialty Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Companion Animal Specialty Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Companion Animal Specialty Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Companion Animal Specialty Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Companion Animal Specialty Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Companion Animal Specialty Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Companion Animal Specialty Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Companion Animal Specialty Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Companion Animal Specialty Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Companion Animal Specialty Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Companion Animal Specialty Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Specialty Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Companion Animal Specialty Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Companion Animal Specialty Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Companion Animal Specialty Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Companion Animal Specialty Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Companion Animal Specialty Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Companion Animal Specialty Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Companion Animal Specialty Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Companion Animal Specialty Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Companion Animal Specialty Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Companion Animal Specialty Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Companion Animal Specialty Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Companion Animal Specialty Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Companion Animal Specialty Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Companion Animal Specialty Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Companion Animal Specialty Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Companion Animal Specialty Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Companion Animal Specialty Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Companion Animal Specialty Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Companion Animal Specialty Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Companion Animal Specialty Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Companion Animal Specialty Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Companion Animal Specialty Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Companion Animal Specialty Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Companion Animal Specialty Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Companion Animal Specialty Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Companion Animal Specialty Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Companion Animal Specialty Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Companion Animal Specialty Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Companion Animal Specialty Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Companion Animal Specialty Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Companion Animal Specialty Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Companion Animal Specialty Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Companion Animal Specialty Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Companion Animal Specialty Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Companion Animal Specialty Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Companion Animal Specialty Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Companion Animal Specialty Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Companion Animal Specialty Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Companion Animal Specialty Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Companion Animal Specialty Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Companion Animal Specialty Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Companion Animal Specialty Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Companion Animal Specialty Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Companion Animal Specialty Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Companion Animal Specialty Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Companion Animal Specialty Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Companion Animal Specialty Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Companion Animal Specialty Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Companion Animal Specialty Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Companion Animal Specialty Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Companion Animal Specialty Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Companion Animal Specialty Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Companion Animal Specialty Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Companion Animal Specialty Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Companion Animal Specialty Drugs Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Elanco Company Information
 Table 76. Elanco Description and Business Overview
 Table 77. Elanco Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Elanco Companion Animal Specialty Drugs Product
 Table 79. Elanco Recent Developments/Updates
 Table 80. Merial Company Information
 Table 81. Merial Description and Business Overview
 Table 82. Merial Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Merial Companion Animal Specialty Drugs Product
 Table 84. Merial Recent Developments/Updates
 Table 85. Zoetis Company Information
 Table 86. Zoetis Description and Business Overview
 Table 87. Zoetis Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Zoetis Companion Animal Specialty Drugs Product
 Table 89. Zoetis Recent Developments/Updates
 Table 90. Aratana therapeutics Company Information
 Table 91. Aratana therapeutics Description and Business Overview
 Table 92. Aratana therapeutics Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Aratana therapeutics Companion Animal Specialty Drugs Product
 Table 94. Aratana therapeutics Recent Developments/Updates
 Table 95. Beaphar Company Information
 Table 96. Beaphar Description and Business Overview
 Table 97. Beaphar Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Beaphar Companion Animal Specialty Drugs Product
 Table 99. Beaphar Recent Developments/Updates
 Table 100. Henry Schein Company Information
 Table 101. Henry Schein Description and Business Overview
 Table 102. Henry Schein Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Henry Schein Companion Animal Specialty Drugs Product
 Table 104. Henry Schein Recent Developments/Updates
 Table 105. Mars Company Information
 Table 106. Mars Description and Business Overview
 Table 107. Mars Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Mars Companion Animal Specialty Drugs Product
 Table 109. Mars Recent Developments/Updates
 Table 110. The J.M Smucker Company Company Information
 Table 111. The J.M Smucker Company Description and Business Overview
 Table 112. The J.M Smucker Company Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. The J.M Smucker Company Companion Animal Specialty Drugs Product
 Table 114. The J.M Smucker Company Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Companion Animal Specialty Drugs Distributors List
 Table 118. Companion Animal Specialty Drugs Customers List
 Table 119. Companion Animal Specialty Drugs Market Trends
 Table 120. Companion Animal Specialty Drugs Market Drivers
 Table 121. Companion Animal Specialty Drugs Market Challenges
 Table 122. Companion Animal Specialty Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Companion Animal Specialty Drugs
 Figure 2. Global Companion Animal Specialty Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Companion Animal Specialty Drugs Market Share by Type: 2024 & 2031
 Figure 4. Vaccines Product Picture
 Figure 5. Antibiotics Product Picture
 Figure 6. Parasiticides Product Picture
 Figure 7. Feed Additives Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Companion Animal Specialty Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Companion Animal Specialty Drugs Market Share by Application: 2024 & 2031
 Figure 11. Veterinary Hospitals
 Figure 12. Pet Care Clinics
 Figure 13. Pharmacy Stores
 Figure 14. Global Companion Animal Specialty Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Companion Animal Specialty Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Companion Animal Specialty Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global Companion Animal Specialty Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 18. Companion Animal Specialty Drugs Report Years Considered
 Figure 19. Companion Animal Specialty Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Companion Animal Specialty Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Companion Animal Specialty Drugs Players: Market Share by Revenue in Companion Animal Specialty Drugs in 2024
 Figure 22. Companion Animal Specialty Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Companion Animal Specialty Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Companion Animal Specialty Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Companion Animal Specialty Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Companion Animal Specialty Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Companion Animal Specialty Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Companion Animal Specialty Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Companion Animal Specialty Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Companion Animal Specialty Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Companion Animal Specialty Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Companion Animal Specialty Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Companion Animal Specialty Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Companion Animal Specialty Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Companion Animal Specialty Drugs by Type (2020-2031)
 Figure 59. Global Companion Animal Specialty Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Companion Animal Specialty Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Companion Animal Specialty Drugs by Application (2020-2031)
 Figure 62. Global Companion Animal Specialty Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 63. Companion Animal Specialty Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS